Related Experiment Video
Updated: Oct 3, 2025

Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
Two cases with mitochondrial membrane protein-associated neurodegeneration: genetic features and long-term clinical
Sevcan Mercan1,2,3, Sibel Aylin Ugur Iseri1, Remzi Yigiter4
1Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Abstract:
Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare neurological disease with childhood or adult onset. It is a subtype of clinically and genetically heterogeneous group of disorders, collectively known as neurodegeneration with brain iron accumulation . MPAN is generally associated with biallelic pathogenic variants in C19orf12. Herein, we describe genetic and clinical findings of two MPAN cases from Turkey. In the first case, we have identified the relatively common pathogenic variant of C19orf12 in the homozygous state, which causes late-onset MPAN. The second case was homozygous for an essential splice-site variation.
Insights
Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare neurological disorder. Genetic analysis revealed homozygous pathogenic variants in C19orf12, contributing to disease presentation.
Area of Science:
- Neuroscience
- Genetics
- Rare Diseases
Background:
- Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare, inherited neurological disorder.
- MPAN is characterized by progressive neurodegeneration and iron accumulation in the brain.
- It is genetically linked to mutations in the C19orf12 gene.
Observation:
- This study presents two cases of MPAN from Turkey.
- Both patients were found to have homozygous pathogenic variants in the C19orf12 gene.
- One case exhibited late-onset MPAN due to a common pathogenic variant, while the other had an essential splice-site variation.
Findings:
- Genetic analysis confirmed homozygous pathogenic variants in C19orf12 in both MPAN cases.
- The identified variants, a common pathogenic variant and a splice-site variation, were associated with MPAN.
- These findings highlight the role of C19orf12 in MPAN pathogenesis.
Implications:
- This research expands the understanding of C19orf12 mutations in MPAN.
- The study contributes to the genetic diagnosis and characterization of MPAN patients.
- Further research into C19orf12 variants may reveal therapeutic targets for neurodegeneration with brain iron accumulation disorders.
More Related Videos
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
07:32Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
Published on: February 9, 2020
Related Concept Videos
Animal Mitochondrial Genetics
ATP Synthase: Mechanism
Mitochondrial Precursor Proteins
Most of the mitochondrial...